世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 MHC-Peptide Tetramer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for MHC-Peptide Tetramer was estimated to be worth US$ 194 million in 2024 and is forecast to a readjusted size of US$ 382 million by 2031 with a CAGR of 10.5% during the forecast... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global market for MHC-Peptide Tetramer was estimated to be worth US$ 194 million in 2024 and is forecast to a readjusted size of US$ 382 million by 2031 with a CAGR of 10.5% during the forecast period 2025-2031.An MHC tetramer is a laboratory tool used to study antigen-specific T cells. It consists of four major histocompatibility complex (MHC) molecules bound to a specific peptide and labeled with a fluorescent tag. These tetramers can bind to T cell receptors (TCRs) on the surface of T cells that recognize the specific peptide-MHC complex. By using flow cytometry, researchers can identify and quantify antigen-specific T cells, making MHC tetramers a valuable tool for immunological studies, including vaccine development, cancer immunotherapy, and infectious disease research. Increased focus on cancer immunotherapy and adoptive T cell therapies is driving demand for MHC tetramers to study antigen-specific T cell responses. This report aims to provide a comprehensive presentation of the global market for MHC-Peptide Tetramer, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of MHC-Peptide Tetramer by region & country, by Type, and by Application. The MHC-Peptide Tetramer market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding MHC-Peptide Tetramer. Market Segmentation By Company BioLegend (Revvity) MBL Life Science (JSR Corporation) ImmunAware ProImmune MedChemExpress (MCE) Creative Biolabs WuXi AppTec KACTUS Creative Biosciences ACROBiosystems ChemPartner Segment by Type MHC-I MHC-II Segment by Application Infectious Disease Research Cancer Immunology Other By Region North America United States Canada Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia-Pacific Europe Germany France U.K. Italy Netherlands Nordic Countries Rest of Europe Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA Chapter Outline Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 2: Detailed analysis of MHC-Peptide Tetramer company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 5: Revenue of MHC-Peptide Tetramer in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world. Chapter 6: Revenue of MHC-Peptide Tetramer in country level. It provides sigmate data by Type, and by Application for each country/region. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc. Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry. Chapter 9: Conclusion. Table of Contents1 Market Overview1.1 MHC-Peptide Tetramer Product Introduction 1.2 Global MHC-Peptide Tetramer Market Size Forecast (2020-2031) 1.3 MHC-Peptide Tetramer Market Trends & Drivers 1.3.1 MHC-Peptide Tetramer Industry Trends 1.3.2 MHC-Peptide Tetramer Market Drivers & Opportunity 1.3.3 MHC-Peptide Tetramer Market Challenges 1.3.4 MHC-Peptide Tetramer Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global MHC-Peptide Tetramer Players Revenue Ranking (2024) 2.2 Global MHC-Peptide Tetramer Revenue by Company (2020-2025) 2.3 Key Companies MHC-Peptide Tetramer Manufacturing Base Distribution and Headquarters 2.4 Key Companies MHC-Peptide Tetramer Product Offered 2.5 Key Companies Time to Begin Mass Production of MHC-Peptide Tetramer 2.6 MHC-Peptide Tetramer Market Competitive Analysis 2.6.1 MHC-Peptide Tetramer Market Concentration Rate (2020-2025) 2.6.2 Global 5 and 10 Largest Companies by MHC-Peptide Tetramer Revenue in 2024 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in MHC-Peptide Tetramer as of 2024) 2.7 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 MHC-I 3.1.2 MHC-II 3.2 Global MHC-Peptide Tetramer Sales Value by Type 3.2.1 Global MHC-Peptide Tetramer Sales Value by Type (2020 VS 2024 VS 2031) 3.2.2 Global MHC-Peptide Tetramer Sales Value, by Type (2020-2031) 3.2.3 Global MHC-Peptide Tetramer Sales Value, by Type (%) (2020-2031) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Infectious Disease Research 4.1.2 Cancer Immunology 4.1.3 Other 4.2 Global MHC-Peptide Tetramer Sales Value by Application 4.2.1 Global MHC-Peptide Tetramer Sales Value by Application (2020 VS 2024 VS 2031) 4.2.2 Global MHC-Peptide Tetramer Sales Value, by Application (2020-2031) 4.2.3 Global MHC-Peptide Tetramer Sales Value, by Application (%) (2020-2031) 5 Segmentation by Region 5.1 Global MHC-Peptide Tetramer Sales Value by Region 5.1.1 Global MHC-Peptide Tetramer Sales Value by Region: 2020 VS 2024 VS 2031 5.1.2 Global MHC-Peptide Tetramer Sales Value by Region (2020-2025) 5.1.3 Global MHC-Peptide Tetramer Sales Value by Region (2026-2031) 5.1.4 Global MHC-Peptide Tetramer Sales Value by Region (%), (2020-2031) 5.2 North America 5.2.1 North America MHC-Peptide Tetramer Sales Value, 2020-2031 5.2.2 North America MHC-Peptide Tetramer Sales Value by Country (%), 2024 VS 2031 5.3 Europe 5.3.1 Europe MHC-Peptide Tetramer Sales Value, 2020-2031 5.3.2 Europe MHC-Peptide Tetramer Sales Value by Country (%), 2024 VS 2031 5.4 Asia Pacific 5.4.1 Asia Pacific MHC-Peptide Tetramer Sales Value, 2020-2031 5.4.2 Asia Pacific MHC-Peptide Tetramer Sales Value by Region (%), 2024 VS 2031 5.5 South America 5.5.1 South America MHC-Peptide Tetramer Sales Value, 2020-2031 5.5.2 South America MHC-Peptide Tetramer Sales Value by Country (%), 2024 VS 2031 5.6 Middle East & Africa 5.6.1 Middle East & Africa MHC-Peptide Tetramer Sales Value, 2020-2031 5.6.2 Middle East & Africa MHC-Peptide Tetramer Sales Value by Country (%), 2024 VS 2031 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions MHC-Peptide Tetramer Sales Value Growth Trends, 2020 VS 2024 VS 2031 6.2 Key Countries/Regions MHC-Peptide Tetramer Sales Value, 2020-2031 6.3 United States 6.3.1 United States MHC-Peptide Tetramer Sales Value, 2020-2031 6.3.2 United States MHC-Peptide Tetramer Sales Value by Type (%), 2024 VS 2031 6.3.3 United States MHC-Peptide Tetramer Sales Value by Application, 2024 VS 2031 6.4 Europe 6.4.1 Europe MHC-Peptide Tetramer Sales Value, 2020-2031 6.4.2 Europe MHC-Peptide Tetramer Sales Value by Type (%), 2024 VS 2031 6.4.3 Europe MHC-Peptide Tetramer Sales Value by Application, 2024 VS 2031 6.5 China 6.5.1 China MHC-Peptide Tetramer Sales Value, 2020-2031 6.5.2 China MHC-Peptide Tetramer Sales Value by Type (%), 2024 VS 2031 6.5.3 China MHC-Peptide Tetramer Sales Value by Application, 2024 VS 2031 6.6 Japan 6.6.1 Japan MHC-Peptide Tetramer Sales Value, 2020-2031 6.6.2 Japan MHC-Peptide Tetramer Sales Value by Type (%), 2024 VS 2031 6.6.3 Japan MHC-Peptide Tetramer Sales Value by Application, 2024 VS 2031 6.7 South Korea 6.7.1 South Korea MHC-Peptide Tetramer Sales Value, 2020-2031 6.7.2 South Korea MHC-Peptide Tetramer Sales Value by Type (%), 2024 VS 2031 6.7.3 South Korea MHC-Peptide Tetramer Sales Value by Application, 2024 VS 2031 6.8 Southeast Asia 6.8.1 Southeast Asia MHC-Peptide Tetramer Sales Value, 2020-2031 6.8.2 Southeast Asia MHC-Peptide Tetramer Sales Value by Type (%), 2024 VS 2031 6.8.3 Southeast Asia MHC-Peptide Tetramer Sales Value by Application, 2024 VS 2031 6.9 India 6.9.1 India MHC-Peptide Tetramer Sales Value, 2020-2031 6.9.2 India MHC-Peptide Tetramer Sales Value by Type (%), 2024 VS 2031 6.9.3 India MHC-Peptide Tetramer Sales Value by Application, 2024 VS 2031 7 Company Profiles 7.1 BioLegend (Revvity) 7.1.1 BioLegend (Revvity) Profile 7.1.2 BioLegend (Revvity) Main Business 7.1.3 BioLegend (Revvity) MHC-Peptide Tetramer Products, Services and Solutions 7.1.4 BioLegend (Revvity) MHC-Peptide Tetramer Revenue (US$ Million) & (2020-2025) 7.1.5 BioLegend (Revvity) Recent Developments 7.2 MBL Life Science (JSR Corporation) 7.2.1 MBL Life Science (JSR Corporation) Profile 7.2.2 MBL Life Science (JSR Corporation) Main Business 7.2.3 MBL Life Science (JSR Corporation) MHC-Peptide Tetramer Products, Services and Solutions 7.2.4 MBL Life Science (JSR Corporation) MHC-Peptide Tetramer Revenue (US$ Million) & (2020-2025) 7.2.5 MBL Life Science (JSR Corporation) Recent Developments 7.3 ImmunAware 7.3.1 ImmunAware Profile 7.3.2 ImmunAware Main Business 7.3.3 ImmunAware MHC-Peptide Tetramer Products, Services and Solutions 7.3.4 ImmunAware MHC-Peptide Tetramer Revenue (US$ Million) & (2020-2025) 7.3.5 ImmunAware Recent Developments 7.4 ProImmune 7.4.1 ProImmune Profile 7.4.2 ProImmune Main Business 7.4.3 ProImmune MHC-Peptide Tetramer Products, Services and Solutions 7.4.4 ProImmune MHC-Peptide Tetramer Revenue (US$ Million) & (2020-2025) 7.4.5 ProImmune Recent Developments 7.5 MedChemExpress (MCE) 7.5.1 MedChemExpress (MCE) Profile 7.5.2 MedChemExpress (MCE) Main Business 7.5.3 MedChemExpress (MCE) MHC-Peptide Tetramer Products, Services and Solutions 7.5.4 MedChemExpress (MCE) MHC-Peptide Tetramer Revenue (US$ Million) & (2020-2025) 7.5.5 MedChemExpress (MCE) Recent Developments 7.6 Creative Biolabs 7.6.1 Creative Biolabs Profile 7.6.2 Creative Biolabs Main Business 7.6.3 Creative Biolabs MHC-Peptide Tetramer Products, Services and Solutions 7.6.4 Creative Biolabs MHC-Peptide Tetramer Revenue (US$ Million) & (2020-2025) 7.6.5 Creative Biolabs Recent Developments 7.7 WuXi AppTec 7.7.1 WuXi AppTec Profile 7.7.2 WuXi AppTec Main Business 7.7.3 WuXi AppTec MHC-Peptide Tetramer Products, Services and Solutions 7.7.4 WuXi AppTec MHC-Peptide Tetramer Revenue (US$ Million) & (2020-2025) 7.7.5 WuXi AppTec Recent Developments 7.8 KACTUS 7.8.1 KACTUS Profile 7.8.2 KACTUS Main Business 7.8.3 KACTUS MHC-Peptide Tetramer Products, Services and Solutions 7.8.4 KACTUS MHC-Peptide Tetramer Revenue (US$ Million) & (2020-2025) 7.8.5 KACTUS Recent Developments 7.9 Creative Biosciences 7.9.1 Creative Biosciences Profile 7.9.2 Creative Biosciences Main Business 7.9.3 Creative Biosciences MHC-Peptide Tetramer Products, Services and Solutions 7.9.4 Creative Biosciences MHC-Peptide Tetramer Revenue (US$ Million) & (2020-2025) 7.9.5 Creative Biosciences Recent Developments 7.10 ACROBiosystems 7.10.1 ACROBiosystems Profile 7.10.2 ACROBiosystems Main Business 7.10.3 ACROBiosystems MHC-Peptide Tetramer Products, Services and Solutions 7.10.4 ACROBiosystems MHC-Peptide Tetramer Revenue (US$ Million) & (2020-2025) 7.10.5 ACROBiosystems Recent Developments 7.11 ChemPartner 7.11.1 ChemPartner Profile 7.11.2 ChemPartner Main Business 7.11.3 ChemPartner MHC-Peptide Tetramer Products, Services and Solutions 7.11.4 ChemPartner MHC-Peptide Tetramer Revenue (US$ Million) & (2020-2025) 7.11.5 ChemPartner Recent Developments 8 Industry Chain Analysis 8.1 MHC-Peptide Tetramer Industrial Chain 8.2 MHC-Peptide Tetramer Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 MHC-Peptide Tetramer Sales Model 8.5.2 Sales Channel 8.5.3 MHC-Peptide Tetramer Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療）の最新刊レポート
QYResearch社の 医療分野 での最新刊レポート
本レポートと同じKEY WORD（demand）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
